Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Gojnic, Miroslava (9434266300)"

Filter results by typing the first few letters
Now showing 1 - 13 of 13
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Cancer during pregnancy - Clinical characteristics, treatment outcomes and prognosis for mothers and infants
    (2018)
    Jeremic, Katarina (6701486495)
    ;
    Stefanovic, Aleksandar (8613866900)
    ;
    Dotlic, Jelena (6504769174)
    ;
    Kadija, Sasa (21739901200)
    ;
    Kontic, Olivera (16678805900)
    ;
    Gojnic, Miroslava (9434266300)
    ;
    Jeremic, Jelena (15022530400)
    ;
    Kesic, Vesna (6701664626)
    To assess which obstetrical characteristics and treatment improved outcomes and prognosis of pregnant women with malignancy. A prospective study, undertaken between 2005 and 2014, involving 35 pregnant women who were diagnosed with malignant tumors during pregnancy. Patients were followed-up for 1 year after delivery. The pregnancy course and outcome and parameters that could influence the condition of mother and fetus were evaluated. Most malignancies were hematological, diagnosed in the second trimester and treated with combined therapy (surgery/adjuvant) after pregnancy. Most fetuses were in good state throughout pregnancy, but were delivered by caesarean section (CS) before term. Adjuvant therapy during pregnancy mostly caused transitory deterioration of fetal conditions. The majority of both mothers and infants were in a good state 12 months postpartum, although numerous mothers were still ill and on therapy. Surviving pregnancy and preventing tumors progression during pregnancy were the best predictors of mothers' future condition (P=0.022). High birthweight and term delivery were the most important factors for good outcome of the infants (P=0.001). If the tumor is not progressing, pregnancy should be continued as long as possible to obtain adequate birthweight of the infant. Second trimester surgery is safe, while other therapies should preferably be applied after delivery. © 2018 Walter de Gruyter GmbH, Berlin/Boston.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Cancer during pregnancy: Twenty-two years of experience from a tertiary referral center
    (2024)
    Milosevic, Branislav (57207556704)
    ;
    Likic Ladjevic, Ivana (12761162800)
    ;
    Dotlic, Jelena (6504769174)
    ;
    Beleslin, Aleksandra (57895738000)
    ;
    Mihaljevic, Olga (58810169700)
    ;
    Pilic, Igor (13612571200)
    ;
    Kesic, Vesna (6701664626)
    ;
    Gojnic, Miroslava (9434266300)
    ;
    Stefanovic, Aleksandar (8613866900)
    ;
    Stefanovic, Katarina (57210793310)
    Introduction: Cancer complicating pregnancy is a rare but potentially life-threatening condition for both the mother and her child. The aim of the present study was to assess the outcomes for mothers and children after pregnancy complicated by malignancy and to investigate which parameters are important for their 1-year survival. Material and methods: The study included 84 pregnant women diagnosed with malignant tumors during pregnancy from 2001 to 2022. The pregnancy course and outcome, as well as parameters that could influence the survival and condition of the mother and child were evaluated. Mothers and children were followed up for 1 year after delivery to assess their condition/complications and overall survival. Results: Most malignancies were gynecological (31%) or hematological (23.8%) and were diagnosed and surgically treated in the second trimester. Most children (69%) showed adequate growth and development throughout pregnancy but were delivered before term (53.6%) to allow mothers to receive therapy. Adjuvant therapy during pregnancy mostly caused a transitory deterioration of the child's condition, while surgery did not significantly impact the pregnancy course. Deliveries, on average, occurred during the 33.01 ± 6.16 gestational week (range: 20–40) and mostly by cesarean section (76.2%). For mothers, the pregnancy survival rate was 95.2% and survival after 1 year was 87.5%. However, 37.5% of women were still ill and required additional therapy 1 year postpartum. The pregnancy survival rate for children was 94%, whereas the 1-year survival rate was 76.2%. Most children had a favorable condition (alive, adequately growing and developing, and without complications) at birth (81%) as well as at the 1-year follow-up (63.7%). Regression analysis identified the following predictors of favorable 1-year maternal condition: applying therapy during pregnancy, no progression of the malignancy during pregnancy, and delivery at a later gestational week. Predictors of favorable 1-year condition of children were lower histopathological grade of malignancy, surgery as therapy for malignancy, obtaining higher birthweight, and delivery by cesarean section. Conclusions: If the malignancy is not progressing, pregnancy should be continued as long as possible for the child to obtain adequate birthweight. Both surgery and chemotherapy were safe therapeutic choices, as most pregnancies continued successfully after therapy. © 2024 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Health Promoting Behaviors among Reproductive Age Women in Serbia: The Results from a National Health Survey
    (2024)
    Todorovic, Jovana (7003376825)
    ;
    Stamenkovic, Zeljka (57188960067)
    ;
    Nesic, Dejan (26023585700)
    ;
    Vojvodic, Katarina (57194084304)
    ;
    Stevanovic, Aleksandar (57224937156)
    ;
    Piperac, Pavle (57188729382)
    ;
    Dugalic, Stefan (26648755300)
    ;
    Gojnic, Miroslava (9434266300)
    ;
    Terzic-Supic, Zorica (15840732000)
    Background: Certain lifestyle characteristics, such as dietary patterns, physical activity, and maintenance of recommended body weight, low-risk alcohol consumption and non-smoking are associated with the lower likelihood for the development of chronic-non communicable disease in the general population. These lifestyles are called health promoting behaviors (HPBs). We aimed to examine the prevalence of the HPBs among the women of reproductive age in Serbia and the factors associated with the compliance with four or more of these behaviors. Methods: The study was the secondary analysis of the data from the National Health survey in Serbia from 2019 that examined social, health status, mental health (using PHQ-8) and lifestyle characteristics of the general population in Serbia. Results: The prevalence of compliance with four or more HPBs was 22%. Among the HPBs the most frequent was a non-risky alcohol consumption reported by 2585 participants (99.2%), followed by normal weight (201869.2%) and non-smoking (1469-69%), daily fruit and vegetables intake (969-33.2%) and sufficient aerobic PA (216-7.9%). Multivariate logistic regression analysis with four or more HPBs as an outcome variable showed that the association of compliance with four or more HPBs with tertiary education (OR 1.91, 95% CI: 1.32-2.76) use of prescription medications (OR: 0.62, 95% CI: 0.44-0.87) and score on PHQ-8 (OR: 0.88, 95% CI: 0.79-0.98). Conclusion: There is a need for deeper promotion of health-related behaviors among all educational and vocational groups, including health promotion activities at the primary health care level, which is available to the entire population. © 2024 Todorovic et al.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Hereditary thrombophilia and low-molecular-weight heparin in women: Useful determinants, including thyroid dysfunction, incorporating the management of treatment and outcomes of the entity
    (2023)
    Dugalic, Stefan (26648755300)
    ;
    Petronijevic, Milica (58134579600)
    ;
    Sengul, Demet (22938589200)
    ;
    Detanac, Dzenana A. (36815573500)
    ;
    Sengul, Ilker (26323870100)
    ;
    De Arruda Veiga, Eduardo Carvalho (44462234600)
    ;
    Stanisavljevic, Tamara (57252613700)
    ;
    Macura, Maja (57219966636)
    ;
    Todorovic, Jovana (7003376825)
    ;
    Gojnic, Miroslava (9434266300)
    OBJECTIVE: Our study purposed to examine the complex relationship between low-molecular-weight heparin therapy, multiple pregnancy determinants, and adverse pregnancy outcomes during the third trimester in women with inherited thrombophilia. METHODS: Patients were selected from a prospective cohort of 358 pregnant patients recruited between 2016 and 2018 at the Clinic for Obstetrics and Gynecology, University Clinical Centre of Serbia, Belgrade. RESULTS: Gestational age at delivery (β=-0.081, p=0.014), resistance index of the umbilical artery (β=0.601, p=0.039), and d-dimer (β=0.245, p<0.001) between 36th and 38th weeks of gestation presented the direct predictors for adverse pregnancy outcomes. The model fit was examined using the root mean square error of approximation 0.00 (95%CI 0.00 0.18), the goodness-of-fit index was 0.998, and the adjusted goodness-of-fit index was 0.966. CONCLUSION: There is a need for the introduction of more precise protocols for the assessment of hereditary thrombophilias and the need for the introduction of low-molecular-weight heparin. © 2023 Associacao Medica Brasileira. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Highlighting early detection of thyroid pathology and gestational diabetes effects on oxidative stress that provokes preterm delivery in thyroidology: Does that ring a bell?
    (2023)
    Dugalic, Stefan (26648755300)
    ;
    Todorovic, Jovana (7003376825)
    ;
    Sengul, Demet (22938589200)
    ;
    Sengul, Ilker (26323870100)
    ;
    Veiga, Eduardo Carvalho de Arruda (44462234600)
    ;
    Plesinac, Jovana (58046514300)
    ;
    Petronijevic, Milica (58134579600)
    ;
    Macura, Maja (57219966636)
    ;
    Kepeci, Sonja Perkovic (57210802062)
    ;
    Milinčić, Miloš (58155347800)
    ;
    Pavlovic, Andrija (57204964008)
    ;
    Gojnic, Miroslava (9434266300)
    Objectives: Ad fontes, the status of the thyroid gland, and metabolic disturbance lead to the alteration of oxygenation. In pregnancy, it is particularly crucial to possess all predictive parameters. Methods: This cross-sectional study was conducted at the Clinic of Gynecology and Obstetrics, Clinical Center of Serbia, Belgrade, Serbia, between 2017 and 2021 which study included a total of 99 women who had been admitted for preterm delivery and had undergone thyroid analysis, detected Hashimoto thyroiditis, and Oral Glucose Tolerance Test (OGTT) 40 days after delivery and had pathological Homeostatic Model Assessment for Insulin Response (HOMA IR) indices. In the group of urgent patients with preterm delivery, we looked after not only routine Doppler of the umbilical artery, but we measured specific ratios such as the Cerebroplacental ratio (CP). Results: The mean maternal age was 32.23 ± 5.96 years and the mean gestational age was detected as 35.40 ± 2.39 weeks. The delivery was completed vaginally in 77 women (78%) and surgically in 22 (22%). The Mean APGAR score was 8.44 ± 1.18, the mean birth weight was 2666.87 ± 622.17g and the cases undergoing cesarean section had significantly higher values of pulsatility index (1.85 ± 0.27 vs. 1.34 ± 0.31) and CP (1.22 ± 0.26 vs. 0.47 ± 0.17). Conclusions: The introduction of Doppler sonography for blood flow assessment helps to form a complete clinical description of the patient, particularly in conditions where oxidative stress became provocative by the thyroid gland antibodies and gestational diabetes in Thyroidology. © 2023 HCFMUSP
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Maternal and Fetal Outcomes among Pregnant Women with Diabetes
    (2022)
    Gojnic, Miroslava (9434266300)
    ;
    Todorovic, Jovana (7003376825)
    ;
    Stanisavljevic, Dejana (23566969700)
    ;
    Jotic, Aleksandra (13702545200)
    ;
    Lukic, Ljiljana (24073403700)
    ;
    Milicic, Tanja (24073432600)
    ;
    Lalic, Nebojsa (13702597500)
    ;
    Lalic, Katarina (13702563300)
    ;
    Stoiljkovic, Milica (57215024953)
    ;
    Stanisavljevic, Tamara (57252613700)
    ;
    Stefanovic, Aleksandar (8613866900)
    ;
    Stefanovic, Katarina (57210793310)
    ;
    Vrzic-Petronijevic, Svetlana (14520050800)
    ;
    Petronijevic, Milos (21739995200)
    ;
    Terzic-Supic, Zorica (15840732000)
    ;
    Macura, Maja (57219966636)
    ;
    Perovic, Milan (36543025300)
    ;
    Babic, Sandra (57489797700)
    ;
    Piperac, Pavle (57188729382)
    ;
    Jovanovic, Marija (59805031900)
    ;
    Parapid, Bijana (6506582242)
    ;
    Doklestic, Krisitna (37861226800)
    ;
    Cerovic, Radmila (57489666400)
    ;
    Djurasevic, Sinisa (57211577561)
    ;
    Dugalic, Stefan (26648755300)
    The aim of this study was to examine the differences in pregnancy complications, delivery characteristics, and neonatal outcomes between women with type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), and gestational diabetes mellitus (GDM). This study included all pregnant women with diabetes in pregnancy in Belgrade, Serbia, between 2010 and 2020. The total sample consisted of 6737 patients. In total, 1318 (19.6%) patients had T1DM, 138 (2.0%) had T2DM, and 5281 patients (78.4%) had GDM. Multivariate logistic regression with the type of diabetes as an outcome variable showed that patients with T1DM had a lower likelihood of vaginal delivery (OR: 0.73, 95% CI: 0.64–0.83), gestational hypertension (OR: 0.47, 95% CI: 0.36–0.62), higher likelihood of chronic hypertension (OR: 1.88, 95% CI: 1.55–2.29),and a higher likelihood ofgestational age at delivery before 37 weeks (OR: 1.38, 95% CI: 1.18–1.63) compared to women with GDM. Multivariate logistic regression showed that patients with T2DM had a lower likelihood ofgestational hypertension compared to women with GDM (OR: 0.37, 95% CI: 0.15–0.92).Our results indicate that the highest percentage of diabetes in pregnancy is GDM, and the existence of differences in pregnancy complications, childbirth characteristics, and neonatal outcomes are predominantly between women with GDM and women with T1DM. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Maternal and Fetal Outcomes among Pregnant Women with Diabetes
    (2022)
    Gojnic, Miroslava (9434266300)
    ;
    Todorovic, Jovana (7003376825)
    ;
    Stanisavljevic, Dejana (23566969700)
    ;
    Jotic, Aleksandra (13702545200)
    ;
    Lukic, Ljiljana (24073403700)
    ;
    Milicic, Tanja (24073432600)
    ;
    Lalic, Nebojsa (13702597500)
    ;
    Lalic, Katarina (13702563300)
    ;
    Stoiljkovic, Milica (57215024953)
    ;
    Stanisavljevic, Tamara (57252613700)
    ;
    Stefanovic, Aleksandar (8613866900)
    ;
    Stefanovic, Katarina (59912734800)
    ;
    Vrzic-Petronijevic, Svetlana (14520050800)
    ;
    Petronijevic, Milos (21739995200)
    ;
    Terzic-Supic, Zorica (15840732000)
    ;
    Macura, Maja (57219966636)
    ;
    Perovic, Milan (36543025300)
    ;
    Babic, Sandra (57489797700)
    ;
    Piperac, Pavle (57188729382)
    ;
    Jovanovic, Marija (59805031900)
    ;
    Parapid, Bijana (6506582242)
    ;
    Doklestic, Krisitna (37861226800)
    ;
    Cerovic, Radmila (57489666400)
    ;
    Djurasevic, Sinisa (57211577561)
    ;
    Dugalic, Stefan (26648755300)
    The aim of this study was to examine the differences in pregnancy complications, delivery characteristics, and neonatal outcomes between women with type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), and gestational diabetes mellitus (GDM). This study included all pregnant women with diabetes in pregnancy in Belgrade, Serbia, between 2010 and 2020. The total sample consisted of 6737 patients. In total, 1318 (19.6%) patients had T1DM, 138 (2.0%) had T2DM, and 5281 patients (78.4%) had GDM. Multivariate logistic regression with the type of diabetes as an outcome variable showed that patients with T1DM had a lower likelihood of vaginal delivery (OR: 0.73, 95% CI: 0.64–0.83), gestational hypertension (OR: 0.47, 95% CI: 0.36–0.62), higher likelihood of chronic hypertension (OR: 1.88, 95% CI: 1.55–2.29),and a higher likelihood ofgestational age at delivery before 37 weeks (OR: 1.38, 95% CI: 1.18–1.63) compared to women with GDM. Multivariate logistic regression showed that patients with T2DM had a lower likelihood ofgestational hypertension compared to women with GDM (OR: 0.37, 95% CI: 0.15–0.92).Our results indicate that the highest percentage of diabetes in pregnancy is GDM, and the existence of differences in pregnancy complications, childbirth characteristics, and neonatal outcomes are predominantly between women with GDM and women with T1DM. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Neurodevelopment of Children Born with Forceps Delivery—A Single Tertiary Clinic Study
    (2024)
    Kostic, Sanja (54682060000)
    ;
    Ivanovic, Katarina (57210170762)
    ;
    Jovanovic, Ivana (59123127600)
    ;
    Petronijevic, Milos (21739995200)
    ;
    Cerovac, Natasa (23476572500)
    ;
    Milin-Lazovic, Jelena (57023980700)
    ;
    Bratic, Danijela (15069128700)
    ;
    Dugalic, Stefan (26648755300)
    ;
    Gojnic, Miroslava (9434266300)
    ;
    Petronijevic, Milica (58134579600)
    ;
    Stojanovic, Milan (59442993200)
    ;
    Rankovic, Ivan (57192091879)
    ;
    Vrzic Petronijevic, Svetlana (14520050800)
    Background and Objectives: Forceps delivery is a crucial obstetrical technique that has become increasingly underutilized in favor of cesarean delivery, despite the numerous complications related to cesarean sections. The major concerns with regard to assisted vaginal birth (AVB) are safety and long-term consequences. We aimed to investigate a neurological outcome of neonates and children at the age of 7 who were born via forceps delivery. This would greatly improve informed decision making for both mothers and obstetricians. Materials and Methods: A single-arm cohort study was conducted from January 2012 to December 2016 among 49 women and their children born via forceps delivery at the Clinic for Gynecology and Obstetrics, University Clinical Center of Serbia. The Sarnat and Sarnat classification was used to evaluate the neurological status of neonates, and logistic regression analysis was employed to explore the association with perinatal factors. Long-term neurological outcomes were assessed using the Griffiths Mental Development Scale and a questionnaire for parents based on the Motor and Social Development (MSD) scale, which was derived from the Bayley-III Scale. Results: The main indication for forceps delivery was maternal exhaustion (79.6%), followed by fetal distress (20.4%). A pathological neurological status was observed in 16.3% of newborns, with pathological ultrasound of the CNS in 3%. A statistically significant association was observed with the Apgar score, with an odds ratio of 0.575 (95% CI: 0.407–0.813, p = 0.002) and perinatal asphyxia, with an odds ratio of 9.882 (95% CI: 1.111–87.902, p = 0.04). However, these associations were unlikely to be related to the mode of delivery. Long-term adverse neurological outcomes were seen in three cases, which accounts for 6.4%. These included mild disorders such as delayed milestone, speech delay, and motor clumsiness. Conclusions: The present study highlights the safety of forceps delivery regarding children’s neurological outcomes at 7 years of age. This is an important contribution to the modern management of labor, especially in light of increasing rates of cesarean deliveries worldwide. © 2024 by the authors.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    New approach of the treatment of von Willebrand's disease during pregnancy.
    (2005)
    Gojnic, Miroslava (9434266300)
    ;
    Fazlagic, A. (23496293200)
    ;
    Likic, I. (23497909500)
    ;
    Stefanovic, A. (8613866900)
    ;
    Vidakovic, S. (9434348100)
    ;
    Pervulov, M. (6602872337)
    ;
    Petkovic, S. (7005164142)
    ;
    Mostic, T. (6506343126)
    ;
    Miljic, P. (6604038486)
    ;
    Bogdanovic, A. (6603686934)
    AIM: The aim of the study was to analyze the effectiveness of the application of DDAVP (desmopressin) and Hemate P with cryoprecipitate pre- and postpartum in patients with von Willebrand disease. METHODS: We monitored 32 patients with von Willebrand disease during the study period 1993-2003. DDAVP was applied in the 36th/37th week of gestation and cryoprecipitate and fresh frozen plasma were applied 1 day before and 3 days after delivery. DDAVP treatment continued for 4 weeks. Factor VIII (Hemate P) at the day of delivery RESULTS: No complications occurred in the studied population. CONCLUSION: Precipitation of DDAVP, Hemate P, and cryoprecipitate may help in the treatment of pregnant women with von Willebrand disease.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Revisiting type II diabetes mellitus in pregnancy and pregnancy outcomes such as in thyroidology: Do you mind?
    (2023)
    Todorovic, Jovana (7003376825)
    ;
    Dugalic, Stefan (26648755300)
    ;
    Sengul, Demet (22938589200)
    ;
    Stanisavljevic, Dejana (23566969700)
    ;
    Detanac, Dzenana A. (36815573500)
    ;
    Sengul, Ilker (26323870100)
    ;
    De Arruda Veiga, Eduardo Carvalho (44462234600)
    ;
    Terzic-Supic, Zorica (15840732000)
    ;
    Duric, Biljana (23472542000)
    ;
    Gojnic, Miroslava (9434266300)
    OBJECTIVE: There is an increase in the prevalence of pre-gestational diabetes in the past decades, mainly due to the increase in the prevalence of obesity in the general population and consequently type 2 diabetes among women of reproductive age. METHODS: This study purposed to describe the delivery characteristics, pregnancy complications, and outcomes among women in Serbia with the pre-gestational type 2 diabetes in the past decade, as well as their pregnancy complications, deliveries, and neonatal outcomes. The study included data from all the pregnant women with pre-gestational type 2 diabetes in Belgrade, Serbia during the period between 2010 and 2020. The final sample consisted of 138 patients. RESULTS: More than half, i.e., 70 (50.7%) had a vaginal delivery, while 48 (34.8%) had elective and 20 (14.5%) had emergency caesarean sections. Throughout the period, there was 1 patient with preeclampsia (0.7%), 5 with pregnancy-induced hypertension (3.6%), 7 had newborns with small for gestational age (5.1%), 28 with macrosomia (20.3%), 12 (8.7%) had preterm births, and one-fifth, i.e., 28 (20.3%) of the newborns had Apgar score under 8. CONCLUSION: The present study revealed that women with type 2 diabetes in pregnancy have a significant burden of pregnancy complications, related to pregnancy, delivery, and newborns. © 2023 Associacao Medica Brasileira. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The effects of adjuvant insulin therapy among pregnant women with IGT who failed to achieve the desired glycemia levels by diet and moderate physical activity
    (2012)
    Gojnic, Miroslava (9434266300)
    ;
    Perovic, Milan (36543025300)
    ;
    Pervulov, Miroslava (6602872337)
    ;
    Ljubic, Aleksandar (6701387628)
    Objective: Evaluation of adjuvant insulin therapy effects on glycemic control, perinatal outcome and postpuerperal glucose tolerance in impaired glucose tolerance (IGT) pregnant women who failed to achieve desired glycemic control by dietary regime. Methods: A total of 280 participants were classified in two groups: Group A patients continued with dietary regime and Group B patients were treated with adjuvant insulin therapy. Glycemic control was assessed by laboratory and ultrasonograph means. Pregnancy outcomes were evaluated by prevalence of pregnancy induced hypertension (PIH), high birth weight, neonatal hypoglycemia and caesarean section rates. Postpuerperal glucose tolerance was assessed by oral glucose tolerance test (oGTT). Results: All laboratory and ultrasound indicators of glycemic control had significantly lower values in Group B. Group A women were more likely to develop the EPH (Edema, Proteinuria, Hypertension) syndrome, 20% versus 7.86% (p0.003). High birth weight occurred more frequently in Group A, but the difference was not significant (p0.197). Higher rate of caesarean delivery was in Group A than in Group B, 16.43% versus 26.43% (p0.041). The difference in neonatal hypoglycemia was not significant (p0.478). Pathological oGTT results were observed in 73 Group A patients and in 15 Group B patients. Conclusion: Lower caesarean section rates and the EPH syndrome incidence are the benefits of adjuvant insulin therapy in IGT patients. © 2012 Informa UK, Ltd.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Trends of the Prevalence of Pre-gestational Diabetes in 2030 and 2050 in Belgrade Cohort
    (2022)
    Dugalic, Stefan (26648755300)
    ;
    Petronijevic, Milos (21739995200)
    ;
    Vasiljevic, Brankica (25121541800)
    ;
    Todorovic, Jovana (7003376825)
    ;
    Stanisavljevic, Dejana (23566969700)
    ;
    Jotic, Aleksandra (13702545200)
    ;
    Lukic, Ljiljana (24073403700)
    ;
    Milicic, Tanja (24073432600)
    ;
    Lalić, Nebojsa (13702597500)
    ;
    Lalic, Katarina (13702563300)
    ;
    Stoiljkovic, Milica (57215024953)
    ;
    Terzic-Supic, Zorica (15840732000)
    ;
    Stanisavljevic, Tamara (57252613700)
    ;
    Stefanovic, Aleksandar (8613866900)
    ;
    Stefanovic, Katarina (57210793310)
    ;
    Vrzic-Petronijevic, Svetlana (14520050800)
    ;
    Macura, Maja (57219966636)
    ;
    Pantic, Igor (36703123600)
    ;
    Piperac, Pavle (57188729382)
    ;
    Jovanovic, Marija (59805031900)
    ;
    Cerovic, Radmila (57489666400)
    ;
    Djurasevic, Sinisa (57211577561)
    ;
    Babic, Sandra (57489797700)
    ;
    Perkovic-Kepeci, Sonja (57715972800)
    ;
    Gojnic, Miroslava (9434266300)
    The aim of this study was to analyze the trends in diabetes in pregnancy in Belgrade, Serbia for the period of the past decade and forecast the number of women with pre-gestational diabetes for the years 2030 and 2050. The study included the data on all pregnant women with diabetes from the registry of the deliveries in Belgrade, by the City Institute of Public Health of Belgrade, Serbia for the period between 2010 and 2020 and the published data on the deliveries on the territory of Belgrade. During the examined period the total number of live births in Belgrade was 196,987, and the prevalence of diabetes in pregnancy was 3.4%, with the total prevalence of pre-gestational diabetes of 0.7% and overall prevalence of GDM of 2.7%. The average age of women in our study was significantly lower in 2010 compared to 2020. The forecasted prevalence of pre-gestational diabetes among all pregnant women for 2030 is 2% and 4% for 2050 in our cohort. Our study showed that the prevalence of pre-gestational diabetes has increased both among all pregnant women and among women with diabetes in pregnancy in the past decade in Belgrade, Serbia and that it is expected to increase further in the next decades and to further double by 2050. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Trends of the Prevalence of Pre-gestational Diabetes in 2030 and 2050 in Belgrade Cohort
    (2022)
    Dugalic, Stefan (26648755300)
    ;
    Petronijevic, Milos (21739995200)
    ;
    Vasiljevic, Brankica (25121541800)
    ;
    Todorovic, Jovana (7003376825)
    ;
    Stanisavljevic, Dejana (23566969700)
    ;
    Jotic, Aleksandra (13702545200)
    ;
    Lukic, Ljiljana (24073403700)
    ;
    Milicic, Tanja (24073432600)
    ;
    Lalić, Nebojsa (13702597500)
    ;
    Lalic, Katarina (13702563300)
    ;
    Stoiljkovic, Milica (57215024953)
    ;
    Terzic-Supic, Zorica (15840732000)
    ;
    Stanisavljevic, Tamara (57252613700)
    ;
    Stefanovic, Aleksandar (8613866900)
    ;
    Stefanovic, Katarina (59912734800)
    ;
    Vrzic-Petronijevic, Svetlana (14520050800)
    ;
    Macura, Maja (57219966636)
    ;
    Pantic, Igor (36703123600)
    ;
    Piperac, Pavle (57188729382)
    ;
    Jovanovic, Marija (59805031900)
    ;
    Cerovic, Radmila (57489666400)
    ;
    Djurasevic, Sinisa (57211577561)
    ;
    Babic, Sandra (57489797700)
    ;
    Perkovic-Kepeci, Sonja (57715972800)
    ;
    Gojnic, Miroslava (9434266300)
    The aim of this study was to analyze the trends in diabetes in pregnancy in Belgrade, Serbia for the period of the past decade and forecast the number of women with pre-gestational diabetes for the years 2030 and 2050. The study included the data on all pregnant women with diabetes from the registry of the deliveries in Belgrade, by the City Institute of Public Health of Belgrade, Serbia for the period between 2010 and 2020 and the published data on the deliveries on the territory of Belgrade. During the examined period the total number of live births in Belgrade was 196,987, and the prevalence of diabetes in pregnancy was 3.4%, with the total prevalence of pre-gestational diabetes of 0.7% and overall prevalence of GDM of 2.7%. The average age of women in our study was significantly lower in 2010 compared to 2020. The forecasted prevalence of pre-gestational diabetes among all pregnant women for 2030 is 2% and 4% for 2050 in our cohort. Our study showed that the prevalence of pre-gestational diabetes has increased both among all pregnant women and among women with diabetes in pregnancy in the past decade in Belgrade, Serbia and that it is expected to increase further in the next decades and to further double by 2050. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback